Effects of estradiol on measurements of conduit artery endothelial function after ischemia and reperfusion in premenopausal women

Canadian Journal of Physiology and Pharmacology

Volumn 94, Issue 12, 2016, Pages 1304-1308

  Luca, Mary Clare ^a,b   Liuni, Andrew ^a,b   Harvey, Paula ^c   Mak, Susanna ^a   Parker, John D ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

Early follicular phase; Endothelium; Estradiol; Flow mediated dilation; Ischemia; Late follicular phase; Reperfusion

Indexed keywords

ESTRADIOL;

ADULT; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; MEAN ARTERIAL PRESSURE; PREMENOPAUSE; PRIORITY JOURNAL; REPERFUSION; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; BLOOD; CROSSOVER PROCEDURE; MENSTRUAL CYCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SINGLE BLIND PROCEDURE; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADOLESCENT; ADULT; BRACHIAL ARTERY; CROSS-OVER STUDIES; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; PREMENOPAUSE; REPERFUSION INJURY; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84994875798     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2015-0589     Document Type: Article

References (22)

1. Abela, C.B., and Homer-Vanniasinkham, S. 2003. Clinical implications of ischaemia-reperfusion injury. Pathophysiology, 9(4): 229–240. doi:10.1016/ S0928-4680(03)00025-7. PMID:14567926.
2. Bolli, R. 2000. The late phase of preconditioning. Circ. Res. 87(11): 972–983. doi:10.1161/01.RES.87.11.972. PMID:11090541.
3. Booth, E.A., Flint, R.R., Lucas, K.L., Knittel, A.K., and Lucchesi, B.R. 2008. Estrogen protects the heart from ischemia-reperfusion injury via COX-2-derived PGI2. J. Cardiovasc. Pharmacol. 52(3): 228–235. doi:10.1097/FJC.0b013e3181824d59. PMID:18806603.
4. Chen, C.-H., Budas, G.R., Churchill, E.N., Disatnik, M.-H., Hurley, T.D., and Mochly-Rosen, D. 2008. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science, 321(5895): 1493–1495. doi:10.1126/science. 1158554. PMID:18787169.
5. Das, B., and Sarkar, C. 2006. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart. J. Cardiovasc. Pharmacol. 47(2): 277–286. doi:10.1097/ 01.fjc.0000202563.54043.d6. PMID:16495767.
6. Dragoni, S., Gori, T., Di Stolfo, G., Sicuro, S., Forconi, S., and Parker, J.D. 2005. Folic acid does not limit endothelial dysfunction induced by ischemia and reperfusion: a human study. J. Cardiovasc. Pharmacol. 46(4): 494–497. doi: 10.1097/01.fjc.0000177983.68563.d1. PMID:16160603.
7. Dragoni, S., Gori, T., Lisi, M., Di Stolfo, G., Pautz, A., Kleinert, H., and Parker, J.D. 2007. Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler., Thromb., Vasc. Biol. 27(9): 1955–1959. doi:10.1161/ ATVBAHA.107.149278. PMID:17641250.
8. Dubey, R.K., Imthurn, B., Barton, M., and Jackson, E.K. 2005. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 66(2): 295–306. doi:10.1016/ j.cardiores.2004.12.012. PMID:15820198.
9. Gori, T., Sicuro, S., Dragoni, S., Donati, G., Forconi, S., and Parker, J.D. 2005. Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study. Circulation, 111(6): 742–746. doi:10.1161/01.CIR. 0000155252.23933.2D. PMID:15699265.
10. Gori, T., Di Stolfo, G., Sicuro, S., Dragoni, S., Lisi, M., Forconi, S., and Parker, J.D. 2007. Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight. Br. J. Clin. Pharmacol. 64(2): 145–150. doi: 10.1111/j.1365-2125.2007.02864.x. PMID:17324239.
11. Gori, T., Dragoni, S., Lisi, M., Di Stolfo, G., Sonnati, S., Fineschi, M., and Parker, J.D. 2008. Conduit artery constriction mediated by low flow: a novel noninvasive method for the assessment of vascular function. J. Am. Coll. Cardiol. 51(20): 1953–1958. doi:10.1016/j.jacc.2008.01.049. PMID:18482663.
12. Guermandi, E., Vegetti, W., Bianchi, M.M., Uglietti, A., Ragni, G., and Crosignani, P. 2001. Reliability of ovulation tests in infertile women. Obstet. Gynecol. 97(1): 92–96. doi:10.1097/00006250-200101000-00019. PMID:11152915.
13. Hashimoto, M., Akishita, M., Eto, M., Ishikawa, M., Kozaki, K., Toba, K., et al. 1995. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation, 92(12): 3431–3435. doi:10.1161/01.CIR.92.12.3431. PMID:8521564.
14. Kharbanda, R.K., Peters, M., Walton, B., Kattenhorn, M., Mullen, M., Klein, N., et al. 2001. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation, 103(12): 1624–1630. doi:10.1161/01.CIR.103.12.1624. PMID:11273988.
15. Lagranha, C.J., Deschamps, A., Aponte, A., Steenbergen, C., and Murphy, E. 2010. Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ. Res. 106(11): 1681–1691. doi:10.1161/CIRCRESAHA.109.213645. PMID:20413785.
16. Liuni, A., Luca, M.C., Gori, T., and Parker, J.D. 2010. Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism. J. Am. Coll. Cardiol. 55(10): 1002–1006. doi:10.1016/j.jacc.2009.11.046. PMID:20202516.
17. Murphy, E., and Steenbergen, C. 2007. Cardioprotection in females: a role for nitric oxide and altered gene expression. Heart Fail. Rev. 12(3–4): 293–300. doi:10.1007/s10741-007-9035-0. PMID:17508281.
18. O’Donnell, E., Harvey, P.J., Goodman, J.M., and De Souza, M.J. 2007. Long-term estrogen deficiency lowers regional blood flow, resting systolic blood pressure, and heart rate in exercising premenopausal women. Am. J. Physiol.: Endocrinol. Metab. 292(5): E1401–E1409. doi:10.1152/ajpendo.00547.2006. PMID:17227959.
19. Rickenlund, A., Eriksson, M.J., Schenck-Gustafsson, K., and Hirschberg, A.L. 2005. Oral contraceptives improve endothelial function in amenorrheic athletes. J. Clin. Endocrinol. Metab. 90(6): 3162–3167. doi:10.1210/jc.2004-1964. PMID:15769986.
20. Thijssen, D.H., Dawson, E.A., Black, M.A., Hopman, M.T., Cable, N.T., and Green, D.J. 2008. Heterogeneity in conduit artery function in humans: impact of arterial size. Am. J. Physiol.: Heart Circ. Physiol. 295(5): H1927–H1934. doi:10.1152/ajpheart.00405.2008. PMID:18775852.
21. Williams, M.R., Westerman, R.A., Kingwell, B.A., Paige, J., Blombery, P.A., Sudhir, K., and Komesaroff, P.A. 2001. Variations in endothelial function and arterial compliance during the menstrual cycle. J. Clin. Endocrinol. Metab. 86(11): 5389–5395. doi:10.1210/jcem.86.11.8013. PMID:11701712.
22. Zhu, B., Sun, Y., Sievers, R.E., Browne, A.E., Pulukurthy, S., Sudhir, K., et al. 2000. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. J. Am. Coll. Cardiol. 35(3): 787–795. doi:10.1016/S0735-1097(99)00592-6. PMID:10716484.